白内障术前LipiFlow治疗对术后睑板腺功能障碍与干眼的影响
这项前瞻性随机对照研究纳入124例计划行老年性白内障手术的患者,随机分为对照组与术前3周接受LipiFlow治疗的LipiFlow组,随访至术后3个月。结果显示,对照组术后睑板腺表达性、睑脂质量、脂质层厚度及角膜染色均恶化,干眼症状加重;LipiFlow组则睑板腺通畅度与睑脂质量改善、泪膜破裂时间延长、角膜染色减轻,且主观评分改善,各参数改善与基线MGD分级呈线性相关。作者认为术前LipiFlow可能安全有效,或可推荐用于伴或不伴基线MGD的患者以预防手术相关MGD与干眼。
要点
- 白内障术前3周行LipiFlow可改善术后睑板腺通畅度与睑脂质量
- LipiFlow组泪膜破裂时间延长、角膜染色减轻、主观干眼评分改善
- 对照术后MGD与干眼指标恶化,LipiFlow组各参数改善与基线MGD分级线性相关
核心结论
- 白内障术前3周行LipiFlow治疗可能是缓解手术所致睑板腺功能障碍与干眼的安全有效干预。
- 作者认为该治疗不仅可推荐用于术前存在MGD的患者,也可用于无基线MGD者以预防手术相关MGD与干眼。
研究设计与样本
- 前瞻性随机对照研究,纳入124例(124眼)计划行老年性白内障手术的患者。
- 按术前3周是否接受LipiFlow治疗随机分为对照组与LipiFlow组,随访至术后3个月。
主要发现
- 对照组术后睑板腺表达性显著下降、睑脂质量恶化、脂质层厚度降低、角膜染色加重,干眼症状显著加重。
- LipiFlow组睑板腺通畅度与睑脂质量显著改善、泪膜破裂时间延长、角膜染色减轻,OSDI与Dry Eye Questionnaire主观结局改善。
- LipiFlow组各参数的改善与基线MGD分级呈线性相关。
- 无基线MGD的患者接受术前LipiFlow后,手术所致MGD与干眼的恶化或改善程度较小。
临床怎么用
- 对计划行白内障手术的患者,可考虑术前3周实施LipiFlow以减轻术后睑板腺功能障碍与干眼。
- 术前评估基线MGD分级有助于预判LipiFlow的改善幅度,无基线MGD者亦可能获益于预防性治疗。
局限性
- 研究随访至术后3个月,缺乏更长期疗效与安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: To investigate the effects of preoperative Lipiflow (Johnson & Johnson, Jacksonville, FL, USA) treatment before cataract surgery on meibomian gland dysfunction (MGD) and dry eye induced by surgery. DESIGN: Prospective, randomized controlled study. METHODS: This study comprised 124 eyes of 124 patients with planned surgery for senile cataract. Participants were randomly allocated into control and Lipiflow groups based on administration of Lipiflow treatment 3 weeks before cataract surgery. For meibomian gland (MG) evaluation, MG atrophy, degree of gland expressibility, and quality of gland secretions were examined at the baseline visit and 1 and 3 months postoperatively. Ocular surface parameters of tear film break-up time, Oxford corneal staining score, and tear film lipid layer thickness were measured at each visit. Ocular Surface Disease Index and Dry Eye Questionnaire were also assessed. RESULTS: The control group exhibited a significant decrease in MG expressibility, worsened meibum quality, decreased lipid layer thickness, and worsened corneal staining after cataract surgery. Also, dry eye symptom showed significant worsening. Conversely, the Lipiflow group showed significantly improved MG patency and meibum quality, increased tear film break-up time, and reduced corneal staining, and presented improved subjective outcomes reported on both Ocular Surface Disease Index and Dry Eye Questionnaire. The improvement of each parameter in the Lipiflow group showed a linear correlation with baseline MGD grade. In addition, patients without baseline MGD showed less worsening or improvement of MGD and dry eye induced by surgery, with preoperative Lipiflow treatment. CONCLUSIONS: Preoperative Lipiflow treatment conducted before cataract surgery may be a safe and effective intervention for relieving MGD and dry eye induced by surgery. It might be recommended not only for the patients with preoperative MGD but also for those without baseline MGD, to prevent the development of MGD and dry eye induced by ocular surgeries.
引用
- Park J, Yoo YS, Shin K, et al. Effects of Lipiflow Treatment Prior to Cataract Surgery: A Prospective, Randomized, Controlled Study. Am J Ophthalmol. 2021. PMID: 33992615. doi:10.1016/j.ajo.2021.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。